Business Standard

Norris Medicines Share Price

Know More
NSEBSE
Stock not traded

14.00-0.26 (-1.82%)

04:01 PM,12th Apr 2024

BSE : 524414

NSE :

Sector : Health care

ISIN Code : INE744C01029

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Apr 12 2024 | 04:01 PM IST

Market Cap (₹ Cr)

0

Turnover (₹ Cr)

0.00

Volume (Shares)

Face Value

10

52-WK High

0.00

52-WK High Date

Invalid date

52-WK Low

0.00

52-WK Low Date

Invalid date

All Time High

0.00

All Time High Date

Invalid date

All Time Low

0.00

All Time Low Date

Invalid date

Norris Medicines Ltd

Norris Medicines Ltd was established in September 1990 as a small scale unit at GIDC Estate Ankleshwar to manufacture non sterile dosage e.g. tablets capsules Liquid Orals Copical ointments. The Company was subsequently converted into Public Limited Company on 7th March 1992. The unit expanded to manufacture Sterile dosage in form of Ampoules & Vials. The Company got into the business in the year 1990. Commercial production of the formulation unit commenced in Nov.'91. The project commence in March 1992. Thereafter the Company came out with a Public Issue aggregating Rs 5 cr in Dec.'93 to expand its existing capacity for tablets capsules etc besides diversifying into bulk drugs and setting up an injectables unit. The project costing Rs 14.21 Crore was financed through loans and equity which got completed in 1995.In 2006 the Company launched Diabetic & Cardiac products; launched Dental product in 2007; launched New Molecule Tolperisone with Paracetamol tablet in 2012; in 2013 it extended Anti malarial range with Artemether Lumefantrine tablet & dry syrup. During the year 2013-14 the Company undertook the upgradation of Sterile Injectable Plant. The Company is one of the leading Indian manufacturers of Injections and Medicinal formulations. The Company is engaged into Health Care Industry and has 2 plants situated at GIDC Ankleshwar Gujarat. Both plants of the Company are WHO cGMP approved. At present it has renovated the Sterile Injectable Plant which is as per international standards.

Norris Medicines Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

14

EPS - TTM (₹) [S]

0.00

P/E Ratio (X) [S]

-1.04

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [S]-13.46
P/B Ratio (₹) [S]-1.04
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

14.00

14.00

Week Low/High

14.00

15.00

Month Low/High

11.97

16.00

Year Low/High

10.05

28.00

All time Low/High

0.60

37.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-4.11%%0.000.03%
1 Month-12.39%%0.780.82%
3 Month-16.22%%2.312.85%
6 Month18.34%%11.8013.77%
1 Year20.79%%22.9426.43%
3 Year90.48%%55.0557.36%

Company Info

Company Information

Managing Director : Vimal D Shah

Independent Director : Hiten Parikh

Independent Director : S A M Azmathullah

Independent Director : Susmita Mahapatra

Company Sec. & Compli. Officer : Prerna Karwa

Registered Office: Plot No 801/P & 802, GIDC Industrial Estate,Ankleshwar,Gujarat-393002 Ph: 91-2646-223462/227530

Email:norrismedicines@gmail.com; contact@norrispharma.co

URL:http://www.norrispharma.com